Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Assets Average: 2011-2024

Historic Assets Average for Ani Pharmaceuticals (ANIP) over the last 14 years, with Dec 2024 value amounting to $1.1 billion.

  • Ani Pharmaceuticals' Assets Average rose 24.59% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 24.59%. This contributed to the annual value of $1.1 billion for FY2024, which is 31.46% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Assets Average of $1.1 billion as of FY2024, which was up 31.46% from $832.3 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Assets Average registered a high of $1.1 billion during FY2024, and its lowest value of $459.0 million during FY2020.
  • In the last 3 years, Ani Pharmaceuticals' Assets Average had a median value of $832.3 million in 2023 and averaged $897.4 million.
  • Data for Ani Pharmaceuticals' Assets Average shows a peak YoY soared of 34.29% (in 2021) over the last 5 years.
  • Over the past 5 years, Ani Pharmaceuticals' Assets Average (Yearly) stood at $459.0 million in 2020, then skyrocketed by 34.29% to $616.4 million in 2021, then grew by 24.25% to $765.8 million in 2022, then rose by 8.67% to $832.3 million in 2023, then skyrocketed by 31.46% to $1.1 billion in 2024.